22.08.2023 • News

Grupa Azoty Plans New Ammonium Nitrate Plant at Polish Fertilizer Site

Polish chemical company Grupa Azoty wants to build a new concentrated ammonium nitrate solution plant at its site in Tarnów, Poland. The company announced that it has signed a contract with Thyssenkrupp Uhde for the preparation of licensing documentation and the supply of all process equipment for the plant.

The new facility is expected to enhance production efficiency by substantially decreasing the energy intensity of the fertilizer manufacturing process and help to reduce energy consumption in the production process by over 250,000 GJ/y, Grupa Azoty said.

The plant, to be built on the existing premises of the company’s Fertilizer business unit, will replace the existing deteriorated and more energy-intensive plant and secure raw material for further production of nitrate fertilizers in Tarnów. Production capacity will be 1,500 t/d of concentrated ammonium nitrate solution (100% equivalent) with a concentration of 94% or 86%.

Grupa Azoty expects that the plant will not only reduce the operating costs of the facility by lowering the consumption of basic raw materials, but also reduce the environmental impact of fertilizer production and the amount of wastewater generated in the process.

Construction is scheduled to begin in the late first quarter/early second quarter of 2024, with completion in the fourth quarter of 2025.

© swisshippo/Getty Images
© swisshippo/Getty Images

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read